Background: Automaticity of cardiac devices is designed to reduce the burden on physicians while securing patient safety. The aim of this study is to elucidate accuracy of automatic adjustment algorithm of pacing output and effectiveness of this feature for time reduction during clinic visits.
Introduction
The number of patients treated for their cardio-vascular diseases with implantable devices such as pacemakers has been growing over the years. Current devices have the capability of continuous cardiac monitoring and storage for long-term trends of cardiac rhythms, episodes and physical conditions. These data are often interrogated and assessed during in-office visits with the use of appropriate programmers. Ever-growing demand for implantable device follow-ups is pushing the clinics' capability to their limits. Reduction of burden by any means would greatly impact the quality of care given by these physicians.
Automaticity in cardiac devices has a potential to address this issue. Automatic configuration of devices started in 1960s with the introduction of inhibitory ventricular pacing mode. 1) Recent advancement in software technology is allowing various electrical parameters to be monitored continuously and reconfigure the device accordingly. 2, 3) Improvement with patient safety could be achieved through periodic pacing threshold monitoring and reprogramming of pacing pulse parameters with physician-defined safety margin by utilizing an algorithm, which automatically adjusts pacing output. This feature is known as automatic capture management. Refinement of pacing output may also increase device longevity by conserving battery energy. 4, 5) Automatic capture management has the potential to reduce the burden on physicians and healthcare economics by minimizing the number of patient visits, since threshold testing is one of the major purposes of frequent clinic visits. The timesaving effectiveness of these features has not yet been fully elucidated in the Japanese medical environment. In this report, accuracy of automatic threshold testing is compared against manual method along with difference in time spent for device checkups.
Methods
This was a prospective, multicenter, observational clinical study conducted at 32 centers in Japan. It was approved by the Institutional Review Board or Medical Ethics Committee at each study center, and was carried out in accordance to Ethical Guidelines for Clinical Studies (Ministry of Health, Labour and Welfare, July 30, 2003, amended on December 28, 2004). Patients with existing and newly implantated pacemakers were both eligible for enrollment. Subjects must be implanted with permanent cardiac pacemakers equipped with an automatic capture management system (Adapta or Sensia series pacemakers, Medtronic, Inc., Minneapolis, MN, USA), and willing to sign the informed consent. Patients with difficulty making scheduled follow-up visits or medical conditions not allowing the use of automatic capture management were excluded. Since automatic capture management does not function in AAI(R) mode, patients with a device programmed with this parameter were also excluded.
Safety and efficacy objectives were predefined. For safety, accuracy of pacing threshold values recorded by automatic capture management was evaluated in atrium (atrial capture management: ACM) and ventricle (ventricular capture management: VCM). ACM/VCM were programmed with either monitor only mode or adaptive mode, which automatically reprogram pacing output with physician determined safety margin after the automatic threshold measurements. These measurements are made daily at a time specified by the physician. During the scheduled follow-up visits, subjects first received conventional device checkups. The device was interrogated, followed by manual pacing threshold testing at pulse width of 0.4 ms. P-and R-wave amplitudes were also measured. After completion, the device was interrogated once again to confirm the most recent pacing voltage threshold configured by ACM and VCM features. The device was reprogrammed, if necessary. The automatic capture management was defined safe when the difference between the most recent ACM/VCM configured voltage threshold and conventional measurements are within the range of À0:25 and 0.5 volts. Since voltage threshold could only be configured in 0.25 V increments in these devices, aforementioned criteria is equivalent to maintaining the difference within a single notch for safety and two notches from a battery consumption standpoint.
Details of ventricular 6) and atrial 7) capture management are described elsewhere. Briefly, VCM algorithm utilizes evoked response to pacing output in the ventricle to confirm capture of myocardium. Since evoked response in the atrium is prone to false detection due to its small electrical reaction, ACM uses two different methods to detect atrial capture. If a patient has stable sinus rhythm, the device selects atrial chamber reset (ACR) method. 8) Atrial test pacing is delivered slightly faster than intrinsic sinus rhythm. If the sinus node was reset, it was determined that the test pace had captured the atrium. When a patient lacks stable sinus rhythm but retains intrinsic atrioventricular conduction (AVC), the device will choose AVC method. 9) Duration between atrial test pace and ventricular sensing will be monitored. If this duration falls within a certain time window, the device would confirm the capture of atrial chamber.
Comparison was made between the time spent on conventional device follow-up and device evaluation utilizing automatic capture management. For both methods, the time was recorded when initiating device interrogation with the programmer, and when ''End Session'' button has been pressed. The time required to make all conventional measurements and to confirm ACM/VCM data from interrogated device report were noted. For physicians who routinely use auxiliary ECG recorder during device checkups, the time required to place and remove ECG electrodes was also measured.
Categorical data were expressed as numbers and percentile. Age of subjects was shown with mean and standard deviation. Box plot was used to demonstrate all other continuous data. Top and bottom of the box represented first and third quartiles. Thick line showed the median, whereas whiskers represented maximum and minimum numbers. Hodges-Lehmann estimator was calculated in order to obtain robust estimation. Paired-sample Wilcoxon signed rank test was used to compare the differences between two sets of samples.
Results

Patient Population
The first enrollment occurred on February 7, 2008, and the final follow-up was completed on February 2, 2010. Data received before the cutoff date of March 12, 2010 was analyzed. Data from a total of 359 enrolled subjects were collected from 32 centers in Japan. The follow-up studies were conducted within the first week of device implantation for 115 (32%) of these subjects. None of the subjects exited the study prior to their scheduled visits. Patient demographics are shown in Table 1 . Forty-three percent of the population was male, and mean age at enrollment was 77:1 AE 11:0 years. Most prominent arrhythmic diagnosis was sick sinus syndrome and atrioventricular block for 38 and 43 percent of subjects, respectively. Comorbidity of these conditions was present in 10% of the population. Atrial tachycardia and/or atrial fibrillation were observed in 17%. At baseline visit, majority of devices was programmed with DDD(R) mode (252/359: 70%). Single-chamber pacing mode was applied to 27% of subjects.
Pacing Threshold Comparison
Valid datasets from both of ACM and conventional measurements were obtained from 231 subjects. Sixty-five (28%) of these subjects completed the follow-up studies within the first week after device implantation. Since the device programming of VVI(R) and VDD mode is incompatible with ACM, the data was not collected from 97 patients. Subjects who were experiencing atrial fibrillation at time of measurements were also excluded. Manual measurement in 12 subjects was unsuccessful due to atrial fibrillation, of which automatic measurement was successful in 7 subjects. There were cases of atrial lead dislodgement, leads exhibiting unreliable sensing, and unstable atrial intracardiac electrocardiograms (ECGs). In two of the cases, the ACM did not function because of high threshold. Statistical analysis by paired-sample Wilcoxon signed rank test concluded that 95% confidence interval of median from observed difference between ACM and conventional measurements was ðÀ0:0625; 0Þ volts. This met the criteria of maintaining the difference within À0:25 and 0.5 volts.
Three hundred forty-eight valid datasets from ventricle pacing thresholds were collected. Of these subjects, 113 (32%) received their devices within a week. Reasons for exclusion were incompatible lead systems and unstable intracardiac ECG. Observed difference between VCM and conventional measurements were deemed nonsignificant, thus fulfilling the safety criteria ( Table 2) .
Distribution of observed pacing threshold is shown in Figure 1 . Median values for all settings were 0.5 volts with the exception of VCM, which was 0.625 volts. Measured data were spread in wide spectrum with deviation toward 0.5 volts. The difference between automatic and conventional measurements falling outside of predefined criteria occurred in 7/231 (3.0%, range: À0:75, 0.625), 5/348 (1.4%: range: À3, 0.875) patients for ACM and VCM, respectively. Within these subjects, the 
Time Required for Device Evaluation
Within the total subject population, average time required to perform conventional pacemaker checkups was 5.2 minutes, whereas 2.0 minutes were spent to confirm ACM and/or VCM data. Median of observed difference in time between conventional and automatic measurements was 2.5 minutes with 95% confidence interval of ð2:5; 3:0Þ. As it may be obvious, dual chamber configurations had the tendency to take more time than single chamber settings ( Table 3) .
In order to assess the possible influence of experience with device checkups, the data was divided into two groups; measurements made by healthcare professionals (167/359: 47%) and sponsor's representatives under physicians' supervision (192/359: 53%). The average time required to perform conventional and automatic checkups for healthcare professionals were 6.9 and 2.8 minutes, respectively. The sponsor's representatives performed the same tasks in 3.8 and 1.3 minutes, respectively. The comparison between the groups indicated that the sponsor's representatives spent significantly less time to perform both tasks (p < 0:001). As shown with total subject population, automatic checkups took significantly shorter time than conventional method for both groups (p < 0:001).
In this study, surface ECG electrodes were placed on 246 out of 359 subjects (69%) during the device follow-up. Average time required to apply and remove the electrodes were 1.5 and 1.3 minutes, respectively. In Figure 2 a schematic drawing of time saving with the use of automatic capture management for subjects with device reprogramming is presented. Average time required for ECG electrode application and removal, conventional device follow-up, and device reprogramming is 2.8, 5.2 and 1.4 minutes, respectively, with a total of 9.4 minutes. If the automatic capture management features were fully utilized and auxiliary ECG was not being observed, the device follow-up time could be reduced to 3.4 (¼ 2:0 þ 1:4) minutes.
Discussion
In this study, safety on the use of ACM and VCM was evaluated. Time saving effectiveness with the use of these features was also assessed. A total of 359 patients were enrolled throughout Japan.
The study demonstrated that pacing threshold measurements of permanent pacemakers made by automatic capture management were statistically equivalent to conventional manual method. Manual measurements in the atria could not be made in twelve subjects due to atrial tachyarrhythmia during their clinic visits. Seven of these subjects had successful automatic measurements. Since the de- vices make multiple attempts in case of unsuccessful threshold measurements, ACM may have additional benefit for patients with paroxysmal atrial fibrillation. There were three documented instances of unstable atrial intracardiac ECG, which caused ACM to fail. It was speculated that the medication to control atrial fibrillation may have been the cause of unstable P-wave. There were a total of 12 cases which did not fulfill the equivalence criteria for the difference in threshold measurements. The test was performed within the first week of implantation for eight of these cases implicating that unstable lead/tissue interaction may cause false readings. Other causes may include physical condition of the individuals, medication, comorbidity, and/or circadian variation. Due to possible loss of capture for the patient who was documented with À3 V of difference between automatic and manual measurements, the clinical data were further evaluated. The device-recorded VCM threshold indicated that the threshold voltage trended between 0.875 and 1.125 volts during the period of one month prior to and 13 months after the study follow-up date. The manual measurements made during subsequent clinic visits confirmed that the readings were within the predefined equivalence criteria. The current Medtronic pacemakers are programmed to perform daily threshold measurements, thus making this feature safer for the patients than periodical clinic visits.
Precautions should be exercised in certain patient populations. During the acute phase after lead implantation, especially in the atrium, automatic threshold tests are prone to false measurements. In order to ensure patient safety, ''Acute Phase Remaining'' parameter may be utilized. When this parameter is activated, the device will not lower the pacing output even if ACM/VCM measured lower threshold. Patients with frequent premature contractions should also be closely followed. As for additional patient safety, the pacing output will only be decreased by 0.125 V when ACM/VCM measured lower pacing threshold. Physician determined ''Amplitude Safety Margin'' and ''Minimum Adapted Amplitude'' parameters are also effective to avoid possible loss of capture. When ACM/VCM is programmed at adaptive mode, the device adjusts its pacing output according to the daily threshold measurements. This would secure patient safety by ensuring capture of myocardium while prolonging device longevity by minimizing battery drainage. 4, 5, 10) During the clinic visits, device reprogramming was done in 21% (77/359) of subjects. There were 47 cases with descriptions of parameter changes, of which 20 subjects had only their pacing output modified. If the pacing output was automatically adjusted using ACM/VCM, these patients could have had shorter clinic visits, or even had the opportunity to skip the visit.
As for the general practice in Japan, diagnostic ECG are recorded in specific examination environment, and in most cases ECG during device followups are only used to verify device functionalities. If the diagnostic reporting features of cardiac devices were fully utilized, it may be unnecessary to connect a patient to an auxiliary ECG recorder. This may contribute to time reduction during the routine checkups.
By combining automaticity of pacemakers and remote monitoring technology for these devices, reduction in the frequency of clinic visits may be achievable while maintaining patient safety. The number of patients implanted with cardiac pacemakers is growing rapidly worldwide with overwhelming burden on device clinics and physicians. Results from studies evaluating the ease of use and the effectiveness of remote monitoring system on ICD 11) and CRT-D 12) patients has demonstrated positive acceptance of this system. A report from Lazarus has shown earlier detection of clinical and device-related events with the use of remote monitoring system by analyzing worldwide database. 13) These results suggest that appropriate implementation of remote monitoring is a safe and effective approach to reducing the workload of device clinicians. Medical economic evaluation when using the remote monitoring system has also been performed in Europe. 14) The influence of cost effectiveness could not be applied directly to global regions, but may affect healthcare expenditure.
The following limitations apply to this study. The pacing threshold is influenced by pharmacological and physiological factors. 15, 16) In this study, automatic measurements were made prior to clinic visits, nominally programmed to perform the task when the subjects are resting, to minimize follow-up time. Therefore, the result may not represent outcomes from simultaneous measurements. The time required to perform threshold measurements highly depends on personal experience with device checkups. Even though the individual experience was not evaluated in this study, a large number of centers were enrolled in order to reflect average procedural time in Japan. A half of the reported measurements were made by sponsor's representatives. This may have acted as a bias toward the outcome, but they were supervised by the physicians and statistical analysis revealed that significantly shorter time was required for both checkup methodologies in this group compared to that of the healthcare professionals alone.
Conclusions
The current study demonstrated that pacing threshold measurements made by ACM and VCM were clinically equivalent to conventional manual method. By fully utilizing automatic capture management features, patients may require less routine clinic visits, thus reducing the ever-expanding workload for physicians.
